Emtruth
1 known investors
emTRUTH is a patient data platform that gathers medical records from hospitals, labs, pharmacies, specialists, and portals into a single secure account owned by the patient, who controls consent-based sharing with providers, caregivers, and researchers. It serves patients in the United States and emphasizes encrypted, HIPAA/SOC2-compliant storage with revocable access permissions.
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2023 | $999.7K |
| National Science Foundation | Phase I | 2022 | $254.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Emtruth do?
- emTRUTH is a patient data platform that gathers medical records from hospitals, labs, pharmacies, specialists, and portals into a single secure account owned by the patient, who controls consent-based sharing with providers, caregivers, and researchers. It serves patients in the United States and emphasizes encrypted, HIPAA/SOC2-compliant storage with revocable access permissions.
- Who are Emtruth's investors?
- Emtruth's investors include 4D Capital.